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High-resolution B-mode ultrasonography in evaluation of
atherosclerosis in uremia
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High-resolution B-mode ultrasonography in evaluation of atheroscle-
rosis in uremia. We sought to determine whether atherosclerosis may be
accelerated in uremic patients on maintenance hemodialysis and investi-
gated the risk factors for carotid and femoral atherosclerosis in such
patients. High-resolution B-mode ultrasonography was used to determine
the intima-media thickness (IMT) of the carotid and femoral arteries in
199 hemodialysis patients and 81 age-matched healthy control subjects.
The IMT values of the carotid and femoral arteries in the hemodialysis
patients were significantly higher than in age-matched control subjects in
most age groups. The IMT values of the carotid or femoral artery were
significantly correlated with age in both the hemàdialysis patients and the
control subjects. There was a significant relationship between the IMT
values of the two arteries in the hemodialysis patients (r = 0.418, P =
0.0001) and in the control subjects (r = 0.321, P = 0.0037). Multiple
regression analysis showed that age, cigarette smoking, and uremic state
were independent risk factors for atherosclerosis of both arteries in the
patients and the control subjects (R2 = 0.174, P < 0.0001; R2 = 0.205, P <
0.0001, respectively). In the hemodialysis patients, the independent risk
factors associated with the extent of the IMT of the carotid artery were
age, cigarette smoking, and serum phosphorus level (R2 = 0.180, P <
0.0001), while those associated with the extent of the IMT of the femoral
artery were age, cigarette-smoking, and serum m-PTH level (R2 = 0.230,
P < 0.0001). The results indicated that hemodialysis patients showed
advanced atherosclerosis in the carotid and femoral arteries compared
with that of age-matched healthy control subjects. Such atherosclerosis in
hemodialysis patients may be associated to some extent with secondary
hyperparathyroidism.
The association between uremia and an increased risk of
cardiovascular disease has been documented in many populations
[1, 2J. Ibels et al [3] demonstrated an increase in atherosclerotic
changes in the arteries of uremic patients. An increased aortic
pulse wave velocity has been observed in patients on hemodialysis
[4]. Since cardiovascular complications are a common cause of
death in uremic patients on maintenance hemodialysis, the early
detection and prevention of atherosclerosis are desirable. Athero-
sclerotic lesions are moderately or severely advanced by the time
they produce clinical signs and symptoms [51. There is little
information on the incidence of asymptomatic atherosclerosis and
the risk factors for this disease in uremic patients on maintenance
hemodialysis.
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High-resolution B-mode ultrasound is increasingly used in
epidemiologic and clinical research to noninvasively study the
atherosclerotic process in the carotid artery. It is assumed that the
atherosclerotic changes in the carotid artery mirror general
atherosclerosis. Ultrasound measurements of the intima-media
thickness (IMT) in the carotid artery have been used as indicators
of coronary atherosclerosis [5]. Information on different stages of
atherosclerotic change has been obtained by combining informa-
tion from B-mode recordings of the carotid and femoral arteries
[6]. Our objective was to assess whether measurement of the IMT
in the carotid and femoral arteries might provide additional
information on the extent of the atherosclerotic disease in uremic
patients on maintenance hemodialysis. Additionally, we investi-
gated the risk factors for atherosclerosis in such patients.
Methods
Subjects
We evaluated 199 Japanese uremic patients on maintenance
hemodialysis (96 men and 103 women, mean age 52.7 years; range
21 to 78 years) and 81 healthy control subjects (36 men and 45
women, mean age 53.4 years; range 22 to 77 years). All uremic
patients were randomly selected from outpatients receiving main-
tenance hemodialysis attending Osaka City University Hospital.
Since diabetes mellitus accelerates atherosclerosis, we excluded
from study any patient with diabetic nephropathy. These patients
had been treated by hemodialysis for a mean duration of 105.2
months (range I to 282 months). They received 12 to 15 hours of
hemodialysis each week using a bicarbonate dialysate (Kindaly
Solution AF-2, Fuso, Japan). Their clinical and biochemical
characteristics are summarized in Table 1. Hemodialysis patients
were matched with healthy control subjects by age, sex, body mass
index (BMI), serum glucose, total cholesterol levels, and history of
cigarette smoking. None of the control subjects had uremia
(serum creatinine < 123.7 .tM), hyperlipidemia, diabetes, hyper-
tension, cardiovascular disease, cerebrovascular disease, or pe-
ripheral vascular disease. Each subject gave informed consent to
participate in the study. Subjects underwent the following assess-
ments: (1) completed a questionnaire on smoking habits and on
any history of coronary heart disease (CHD); (2) were subjected
to blood sampling for measurement of biochemical variables
either once a month for six months in the hemodialysis group, or
within seven days before ultrasonographic examination in the
control group, and (3) measurement of IMT of the carotid and
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Table 1. Clinical characteristics
Control group(N = 81)
Patient group
(N = 199)
Age years 52.7 14.1 53.4 10.8
Gender (M/F) 36/45 96/103
Body mass index kg/rn2 22.0 3.5 21.3 2.8
Duration of hemodialysis months 105.2 73.3
Serum glucose mM 5.09 0.20 5.21 0.86
Total cholesterol mM 4.23 0.46 4.17 0.91
Triglyceride mit 0.98 0.17 1.49 0.77
HDL cholesterol msx 1.28 0.15 1.00 0.31'
Total calcium mM 2.31 0.16
Phosphorus mivi 1.92 0.36
m-PTH pg/mi 21247 21640
Systolic blood pressure mm Hg 121.4 7.8 145.4 21.8'
Diastolic blood pressure mm Hg 69.6 5.4 79.5 lola
Cigarette-years 252.3 416.1 265.5 444.1
Data are expressed as mean so. Abbreviations are: M, male; F,
female; HDL cholesterol, high-density lipoprotein cholesterol.
ap < 0.01 vs. control group
femoral arteries using high-resolution real-time ultrasonography
in both groups.
Blood pressure
Blood pressure was recorded after the subject had rested for at
least 10 minutes. Blood pressure was determined with a standard
mercury sphygmomanometer and cuffs adapted to arm circumfer-
ence. The systolic blood pressure was taken as the point of
appearance of Korotokof sounds, and the diastolic blood pressure
as the point of disappearance of the sounds. Results are reported
as the average of three measurements. The presence of hyperten-
sion was defined by (a) the administration of antihypertensive
agents and/or a history of this disorder; (b) a systolic blood
pressure greater than 160 mm Hg; or (c) a diastolic blood pressure
greater than 95 mm Hg.
Smoking
Information on smoking habits was obtained by a self-admin-
istered questionnaire. Life-long exposure to smoking was esti-
mated as the product of years smoked and the number of tobacco
products smoked daily at the time of ultrasonographic examina-
tion. The product was used in statistical analysis as cigarette-years.
Biochemical analysis
Blood was withdrawn after an overnight fast for the analysis of
serum concentrations of calcium, phosphorus, parathyroid hor-
mone, total cholesterol, triglyceride, and high-density lipoprotein
cholesterol (HDL cholesterol). Serum cholesterol, triglyceride
and HDL cholesterol were measured enzymatically using com-
mercially available kits (Cholesterol HRB, Wako Pure Chemical
Industries, Osaka, Japan; Clinimate TG, Daiichi Pure Chemical,
Tokyo, Japan; Daitest CHO-2, Daiichi Pure Chemical, Tokyo,
Japan). Serum calcium and phosphorus were measured by routine
laboratory methods. Parathyroid hormone (m-PTH) was mea-
sured by radioimmunoassay using antibodies that recognized the
mid-region of the peptide hormone (PTH-HS, Yamasa Shoyu,
Tokyo, Japan) [7]. Patients were considered dyslipidemic if they
were taking antihyperlipidemic agents, and/or if the serum cho-
lesterol level was >5.69 m'vi (220 mg/dl), HDL cholesterol was
<1.03 mivi (40 mg/dl), or if triglycerides were >1.70 mi (150
mg/dl), according to the criteria of the Japan Atherosclerosis
Society.
Ultrasonography
Ultrasonographic scanning of the carotid and femoral arteries
was performed with a high resolution real-time ultrasonography
with 10 MI-li in-line Sectascanner (SSD 650 CL, Aloka Co. Ltd,
Tokyo, Japan). The aperture of the scanner was 56 mm. Axial
resolution of this system was less than 0.3 mm. Each subject was
examined in the supine position. The carotid and the femoral
arteries were investigated bilaterally. The carotid artery was
scanned at the level of the bifurcation and the common carotid
artery. The examination included approximately 4 cm of the
common carotid artery, the carotid bulb, and 1 cm each of the
internal and external arteries. The femoral artery was examined
distal to the inguinal ligament at the site where the artery divides
into the superficial and the profound femoral artery. The femoral
artery was scanned approximately 4 cm proximal and 1 cm distal
to the flow divider. These regions were scanned bilaterally in the
longitudinal and the transverse projections. The image was fo-
cused on the far wall of these arteries. The site of the most
advanced atherosclerotic lesion and the projection that showed
the greatest distance between the lumen-intimal interface and the
media-adventitia interface (intima-media thickness: IMT), was
located in both the right and left carotid and femoral arteries [8].
The scan converter (Nexus Co Ltd. Osaka, Japan) provided a wide
dynamic range and a pixel size of 0.047 mm. Images were
displayed with a constant fourfold magnification. All scanning and
measurements were performed with a single ultrasound system.
IMT was measured from the digitized still images of the arteries
during scanning. IMT was defined as the distance between the
leading edge of the lumen-intima interface to the leading edge of
the media-adventitia interface of the far wall. Three still images
from the same section of the artery were measured, and mean
value was calculated.
Intraobserver variability
A total of 40 subjects, 20 from the hemodialysis group and 20
control subjects, were examined on two different occasions sepa-
rated by 7 to 14 days to estimate the intraobserver variability of
the recording and measurement of IMT in the carotid and
femoral arteries. The two recordings and the measurements were
conducted by the same examiner, who was blinded with regard to
the results of the first examination and to the subjects' clinical
characteristics. The correlation between the first and second
measurements was: control subjects, 0.969 in the carotid artery
and 0.992 in the femoral artery; hemodialysis group, 0.961 in the
carotid artery and 0.984 in the femoral artery. The coefficient of
variation for IMT in the carotid artery of the control subjects was
3.6% and that in the femoral artery was 2.8%. The coefficient of
variation for IMT in the hemodialysis group was 3.3% for the
carotid artery and 3.2% in the femoral artery.
Statistical analysis
Data are expressed as mean SD. Differences between groups
were compared with Student's t-test. IMT values in the hemodi-
alysis group were compared with those in control group by the
Mann-Whitney's U-test. Relationships between IMT values and
age were examined by linear regression analysis. The slopes of the





































regression analysis with a forward elimination procedure was used
to assess the combined influence of variables on IMT values.
Model 1 used the following variables: age, sex, cigarette-years,
presence of hypertension, presence of dyslipidemia, and presence
of uremic state. Model 2 used the following variables: age, sex,
BMI, cigarette-years, duration of hemodialysis, history of CHD,
systolic and diastolic blood pressure, serum total cholesterol,
HDL cholesterol, triglyceride, calcium, phosphorus, m-PTH, and
use of la-hydroxyvitamin D3. Sex, history of CHD, hypertension,
dyslipidemia, and uremic state were represented by dummy
variables (0, male; 1, female; 0, presence; 1, absence). Because of
their nonnormal distribution, values for serum triglyceride, and
m-PTH were logarithmically transformed before regression anal-
ysis was performed. In the hemodialysis group, the mean values of
six measurements of BMI, blood pressure, and biochemical
parameters obtained each month for six months before the
ultrasound study was used for statistical analysis. A value of P <
0.05 was considered statistically significant. These procedures




The IMT values of the carotid artery in the hemodialysis group
<40 years of age (0.730 0.090 mm, N = 16), 40 to 49 years of
age (0.892 0.296 mm, N = 55) or 50 to 59 years of age (1.104
0.658 mm, N = 74) significantly exceeded those in the
age-matched control subjects (0.639 0.101 mm, N = 13; 0.746
0.094 mm, N = 12; 0.861 0.236 mm, N = 32, respectively). The
IMT of the carotid artery in the hemodialysis group  60 years of
age (1.525 1.096 mm, N 54) was greater (but not significantly)
than that in age-matched control subjects (1.023 0.278 mm, N =
24). The IMT of the carotid artery in uremic patients on mainte-
nance hemodialysis was equivalent to that of control subjects who
were more than ten years older than those patients (Fig. 1).
Femoral IMT
The IMT of the femoral artery in the hemodialysis group <40
years of age (0.788 0.166 mm, N = 16) was not significantly
greater than that in the age-matched control subjects (0.724
0.174 mm, N = 13). The IMT of the femoral artery in the
hemodialysis group 40 to 49 years of age (1.297 0.773 mm, N =
55), 50 to 59 years of age (1.618 1.109 mm, N = 74) or 60
years of age (2.260 1.707 mm, N = 54) significantly exceeded
that in the age-matched control subjects (0.863 0.217 mm, N =
12; 1.026 0.474 mm, N = 32; 1.136 0.449 mm, N = 24,
respectively). The IMT of the femoral artery in uremic patients on
maintenance hemodialysis was equivalent to that of control
subjects who were more than twenty years older than those
patients (Fig. 2).
Relationships between IMT and age
The relationship between the IMT of carotid and femoral
arteries and age showed correlation coefficients of r = 0.311 (P =
0.0001) and r = 0.358 (P = 0.0001) in the hemodialysis group as
well as in the control subjects (r = 0.526, P = 0.0001; r = 0.477,P = 0.0001, respectively; Figs. 3 and 4). The slope of the
regression line for each artery was significantly steeper in the
hemodialysis group than in the control subjects (carotid artery,
P < 0.001; femoral artery, P < 0.001).
Relationship between IMT and duration of hemodialysis
No relationship was found between IMT of the carotid or
femoral artery and the duration of hemodialysis (R2 =0.003, P =
0.5126; R2 = 0.008, P = 0.246, respectively).
Relationship between carotid and femoral IMT
A significantly positive correlation between the IMT values of
the carotid artery and of the femoral arterys was found in the
control subjects (r = 0.321, P = 0.0037; Fig. 5). We also observed
a significantly positive correlation between these values in the
hemodialysis group (r = 0.418, P = 0.0001; Fig. 6).
0
(13) (16) (12) (55) (32) (74) (24) (54) (81)(199)
39 40—49 50—59 60 Total
Age, years
Fig. 1. Bar graphs showing mean (SD) values of carotid intima-media
thickness (IMT) in control subjects (N = 81; ) and hemodialysis patients(N = 199; U) according to age. Parenthesis indicates number of subjects.
< 0.01 versus control subjects; * * < 0.05 versus control subjects.
39 40—49 50—59 60 Total
Age, years
Fig. 2. Bar graphs showing mean (SD) values of femoral intima-media
thickness (IMT) in control subjects (N = 81; LII) and hemodialysis patients(N = 199; U) according to age. Parenthesis indicates number of subjects.
P < 0.01 versus control subjects; P < 0.05 versus control subjects.







Fig. 3. Relationship between carotid intima-media thickness (IMT) and age
in control subjects (O) and hemodialysis patients (S-).
Age, years
Fig. 4. Relationship between femoral intima-media thickness (IMT) and age
in control subjects (O) and hemodialysis patients (•-).
Femoral IMT, mm
Fig. 5. Relationship between carotid and femoral intima-media thickness
(IMT) in control subjects. r 0.321; P 0.0001.
0
0 1.0 2.0 3.0 4.0 5.0
Femoral IMT, mm
Fig. 6. Relationship between carotid and femoral intima-media thickness
(IMT) in hemodialysis patients. r = 0.418; P = 0.0001.
Effect of uremic state on carotid and femoral IMT (Model 1) Discussion
Multiple regression analysis of data on the patients and the
control subjects showed that the risk factors associated with IMT
values of the carotid and femoral arteries were age, cigarette
smoking and presence of uremia (R2 = 0.174, P < 0.0001; R2 =
0.205, P < 0.0001, respectively; Table 2).
Analysis of risk factors in hemodialysis patients (Model 2)
Multiple regression analysis showed these risk factors to be
associated with IMT values of the carotid artery in uremic patients
on maintenance hemodialysis: age, cigarette smoking, and serum
level of phosphorus (R2 = 0.180, P < 0.0001). Risk factors
associated with IMT values of the femoral artery in the patients
were age, serum m-PTH, and cigarette smoking (R2 = 0.230, P <
0.0001; Table 3).
The present study is the first to evaluate the IMT of the carotid
and the femoral arteries of uremic patients on maintenance
hemodialysis using high-resolution B-mode ultrasound. We ob-
served a significant increase in the intima-media thickness in the
carotid and femoral arteries of the uremic patients on mainte-
nance hemodialysis compared with the age-matched control sub-
jects.
Consistent with previous reports [9—11] that demonstrated that
the extent of the IMT of the carotid artery is significantly
correlated with age in the general population, we found a
significantly positive correlation between IMT and age in the
uremic patients on hemodialysis as well as in the control subjects.
The IMT values of the carotid and femoral arteries in most age
groups were higher in the hemodialysis patients than in the
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Table 2. Risk factors affecting IMT of the carotid and femoral
arteries in all subjects
Variables



















Significant predictors of carotid and femoral intima-media thickness
(IMT) were explored among the parameters including age, gender (male
= 0, female = 1),cigarette-years, history of coronary heart disease (absent
= 0, present = 1), hypertension (absent = 0, present = 1), dyslipidemia(absent = 0, present = 1), and uremic state (absent = 0, present = 1). F
value to enter was set at 4.0 at each step. Final results are given in the
Table. /3 is standard regression coefficient; R2 is multiple coefficient of
determination.
subjects without major coronary risk factors exaggerated the
differences between the two groups in the present study. We
therefore have performed multiple regression analysis (Model 1),
including age, sex, cigarette-years, presence of hypertension,
presence of dyslipidemia, and the presence of the uremic state, to
determine the combined impact of these variables on IMT values.
Such analysis revealed that the uremic state contributed indepen-
dently to the IMT of both arteries among all subjects. The IMT of
neither artery was associated with the duration of hemodialysis by
either simple or multiple regression analysis. Results suggest that
atherosclerosis may be accelerated by the uremic state per se
rather than by hemodialysis. This is consistent with the results of
Rostand, Kirk and Rutsky [12] who suggested that atherosclerosis
may not be accelerated by hemodialysis itself. However, we did
not determine the IMT or the risk factors that existed before the
initiation of hemodialysis in our study, and are therefore uncer-
tain whether our patients may have had advanced atherosclerosis
before the hemodialysis was initiated.
Multiple regression analysis showed that age, cigarette smok-
ing, and the serum level of phosphorus contributed independently
and significantly to the extent of the IMT of carotid artery in the
uremic patients on maintenance hemodialysis. These variables
accounted jointly for 18% of the variation in the IMT of the
carotid artery. The strongest predictors of the extent of the
femoral artery were age, serum level of m-PTH, and cigarette
smoking. These variables jointly explained 23% of the variation in
the IMT of the femoral artery. The association between athero-
sclerosis of the extracranial carotid and the coronary arteries was
confirmed by studies using B-mode ultrasonography [13, 14]. The
extent and severity of extracranial carotid atherosclerosis and
coronary atherosclerosis were strongly correlated in autopsy stud-
ies, whereas the relationship between the coronary and femoral
atherosclerosis was weak [151. We investigated risk factors for
carotid and femoral atherosclerosis and compared the impact of
the major coronary risk factors and calcium metabolism on
atherosclerosis of those arteries in uremic patients on mainte-
nance hemodialysis. Age and cigarette smoking were associated
with the IMT of both arteries. A relationship between the extent
of atherosclerosis and cigarette smoking has been shown [16, 17].
Our study groups were matched for age, sex, BMI, and serum
Table 3. Risk factors affecting IMT of the carotid and femoral arteries
in hemodialysis patients
Variable


















11.414 0.230 (P < 0.0001)
Significant predictors of carotid and femoral intima-media thickness
(IMT) were explored among the parameters including age, gender (male
= 0, female = 1), cigarette-years, body mass index, history of coronary
heart disease (absent = 0, present = 1), duration of hemodialysis, systolic
and diastolic blood pressure, total cholesterol, HDL cholesterol, log(tri-
glyceride), total calcium, phosphorus, log(m-PTH) and use of lo-hy-
droxyvitamin D3. F value to enter was set at 4.0 at each step. Final results
were given in the Table. /3 is standard regression coefficient; R2 is multiple
coefficient of determination.
cholesterol, and their exposure to cigarette smoking was similar.
The two groups differed as to their systolic and diastolic blood
pressure, serum triglyceride level, and HDL cholesterol level.
Arterial hypertension is a well-recognized risk factor for athero-
sclerosis [18, 19]. However, the Finnish Study did not find a
correlation between blood pressure and carotid lesions in a
general population [20]; Lusiani, Visolà and Pagnan [21], using a
device with different technical characteristics, failed to demon-
strate any correlation between stenosis of the carotid artery and
the duration of hypertension in hypertensive patients free of
cardiovascular symptoms. We could not confirm the role of blood
pressure as a major determinant of the IMT of either the carotid
or femoral artery. A study by Vincenti et al [22] showed that the
rigorous control of hypertension in the incipient stages of renal
failure may significantly reduce the incidence of ischemic heart
disease following the initiation of hemodialysis. In our study, most
of the hypertensive hemodialysis patients had received long-term
antihypertensive treatment that may have had a beneficial effect
on the arterial wall. Blood pressure is often unstable in hemodi-
alysis patients because of autonomic neuropathy [23]. Therefore,
these factors may make it difficult to evaluate its influence on
carotid and femoral atherosclerosis.
Patients with end-stage renal disease exhibit lipid abnormalities
[24—26]. In the present study, the serum triglyceride level was
significantly higher, and the serum HDL cholesterol level was
significantly lower, in the hemodialysis patients versus the control
subjects. However, using a multivariate analysis we failed to find
any relationship between IMT and serum cholesterol, triglyceride,
or HDL cholesterol. The serum concentration of lipids and
lipoproteins has been related to carotid atherosclerosis in most [8,
27], but not all reports [28, 29]. The duration of exposure to risk
factors in patients with chronic disorders such as uremia who are
receiving hemodialysis is difficult to estimate. The exposure to risk
factors may change during the progression of renal failure. That
is, uremic patients are often hypercholesterolemic and/or hyper-
triglycemic prior to dialysis, while during dialysis they exhibit such
common lipid abnormalities as an elevated serum level of triglyc-
eride and a reduced serum level of HDL cholesterol [25]. We
observed similar changes in serum lipids in our uremic patients.
These patients reportedly have elevated serum levels of very-low
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density lipoprotein (VLDL) and of intermediate density lipopro-
tein (IDL) [30, 311, with the low density lipoprotein (LDL)
cholesterol usually remaining within the normal range [32]. Al-
though the contribution of VLDL to atherosclerosis is controver-
sial [331, IDL is generally regarded as an atherogenic class of
lipoproteins [34—36]. In addition to the dyslipidemia, the en-
hanced oxidation of LDL observed in uremic patients in vitro and
in vivo may be involved in the atherosclerotic process [371.
Therefore, in uremic patients, abnormalities in lipoprotein com-
position or in LDL oxidation, rather than the elevation of
lipoprotein levels, may be atherogenic. Accordingly, it would not
be surprising that serum lipid levels would not predict the
development of atherosclerosis, as in our patients.
Interestingly, multiple regression analysis of data on the hemo-
dialysis patients showed that carotid atherosclerosis was indepen-
dently associated with the serum level of phosphorus, and that
femoral atherosclerosis was independently associated with the
serum level of m-PTH. An increase in the level of serum
phosphorus and PTH, and a decrease in the level of 1,25-
dihydroxyvitamin D1, are common in uremic patients on mainte-
nance hemodialysis. It has been demonstrated that 1,25-dihy-
droxyvitamin D3 suppresses rat vascular smooth muscle cell
growth [38]. Vitamin D3 and its synthetic analogue, 22-oxa-l,25-
dihydroxyvitamin D3, each stimulates the production of prostacy-
din by vascular tissues [39]. This suggests that a deficiency of
1,25-dihydroxyvitamin D3, but not of calcium, in secondary hyper-
parathyroidism may contribute to the acceleration of atheroscle-
rosis in uremic patients on maintenance hemodialysis. A previous
experimental study demonstrated a relationship between calcium
and lipoprotein metabolism [40]. Shoji et al reported that, in
uremic patients, the plasma HTGL level was independently
associated with ionized calcium and PTH levels, and that the
LCAT level was independently associated with the ionized cal-
cium level. [26]. These data indicate that impaired calcium
metabolism in secondary hyperparathyroidism in patients on
maintenance hemodialysis results in lipoprotein abnormalities via
impairment of the lipoprotein-regulating enzymes. Since an ab-
normality of lipoprotein metabolism was associated with a de-
rangement of calcium metabolism in uremic patients, elevated
serum levels of phosphorus and PTH that affect lipoprotein
metabolism may then contribute to the acceleration of atheroscle-
rosis.
Cardiovascular complications are still the major cause of mor-
bidity and mortality in uremic patients on maintenance hemodi-
alysis. The measurement of the IMT of the carotid and femoral
arteries in the present study demonstrated that atherosclerosis
was accelerated in uremic patients on maintenance hemodialysis.
From these data, we conclude that elevated serum levels of
phosphorus and parathyroid hormone, in addition to age and
smoking, are related to the risk for atherosclerosis in such
patients. The management of secondary hyperparathyroidism may
be beneficial in preventing the atherosclerosis as well as renal
osteodystrophy in these patients.
Reprint requests to Takahiko Kawagishi, M.D., 1—5-7, Asahi-machi,
Abeno-ku, 545 Osaka, Japan.
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